Walleye Trading LLC Aerie Pharmaceuticals Inc Put Options Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $11,320 - $16,630	1,000 New	1,000 $11,000
Q3 2020 Nov 16, 2020	SELL	$10.46 - $14.46 $135,980 - $187,980	-13,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $30,000 - $40,325	2,500 Added 23.81%	13,000 $192,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $24,864 - $53,592	-2,100 Reduced 16.67%	10,500 $142,000
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $186,060 - $263,550	10,500 Added 500.0%	12,600 $305,000
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $23,933 - $36,400	1,300 Added 162.5%	2,100 $40,000
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $23,176 - $38,568	800 New	800 $24,000
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $184,800 - $336,224	-5,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $258,290 - $339,940	4,600 Added 460.0%	5,600 $345,000
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $35,805 - $42,700	-700 Reduced 41.18%	1,000 $54,000
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $86,445 - $110,669	1,700	1,700 $102,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.